PYRGF — PyroGenesis Canada Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1743344 ·
Last close
$0.16
Market Cap
$35.77M
52W High
$0.52
52W Low
$0.12
ADV30
81,500
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,424,678 | 1,396,918 | -1,842,002 | -1,130,984 | 16,158,548 | 1,310,328 | 19,988,477 |
| Mar 2026 | 4,872,563 | 1,569,291 | -801,323 | -1,027,998 | 17,536,756 | 526,220 | 26,560,857 |
| Dec 2025 | 3,327,482 | 556,881 | -5,169,181 | -5,322,637 | 17,285,484 | 1,088,707 | 27,714,402 |
| Sep 2025 | 3,249,540 | 774,346 | -1,991,735 | -2,258,544 | 18,940,693 | 100,349 | 29,808,407 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,949,287
Investing CF
$2,665,540
Financing CF
$7,584,724
CapEx
$-157,668
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-144,350,462
Inventory
$2,339,701
Receivables
$6,591,986
ST Investments
—
EBIT TTM
$-10,551,060
Pretax Income TTM
$-11,627,691
Interest Exp TTM
$1,076,631
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,874,264
EBITDA
$-8,992,802
Free Cash Flow
$-9,090,986
Enterprise Value
$33,516,192
Total Cash
$1,310,328
Total Debt
$2,705,564
Shares Out
226,363,329
Trailing EPS
$-0.04
Book Value
$-0.01
ROE
—
ROA
-32.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 12,572,204 | -12,754,720 | -14,758,682 | 17,285,484 | 27,714,402 | -10,428,918 | -10,094,513 |
| Dec 2024 | 15,652,321 | -6,489,594 | -6,674,750 | 29,200,675 | 32,664,063 | -3,463,388 | -2,100,775 |
| Dec 2023 | 12,345,081 | -27,074,700 | -28,504,174 | 28,435,351 | 31,263,928 | -2,828,577 | -12,045,503 |
| Dec 2022 | 19,013,503 | -23,199,520 | -32,167,027 | 47,666,750 | 30,797,823 | 16,868,927 | -11,128,885 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | $35.36M | $3.52 | — |
| FLNA | FILANA THERAPEUTICS, INC. | $36.23M | $0.75 | — |
| KPTI | Karyopharm Therapeutics Inc. | $36.74M | $1.62 | — |
| NNVC | NANOVIRICIDES, INC. | $36.76M | $1.44 | — |
| BCTX | BriaCell Therapeutics Corp. | $37.58M | $4.32 | — |
News headlines (Yahoo Finance, 1h cache)
PyroGenesis Receives Project Certification from Tata Steel for Major Steel Plant Project
2026-09-22 11:00 · Yahoo
PyroGenesis Signs First Contract Toward New Titanium Powder Supply Agreement with U.S. Materials Distributor
2026-09-15 11:00 · Yahoo
PyroGenesis Comments on Recently Announced Tariffs
2026-09-14 11:00 · Yahoo
PyroGenesis Announces Second Titanium Powder Contract with Metal Additive OEM Client
2026-08-31 11:00 · Yahoo
PyroGenesis Announces Second Titanium Powder Contract with DoD and NASA-Supported U.S. Applied Research Facility Client
2026-08-26 11:00 · Yahoo
PyroGenesis Announces Titanium Powder Contract with Metal Additive OEM
2026-08-24 11:00 · Yahoo
PyroGenesis Announces Titanium Powder Contract with a DoD and NASA-Supported U.S. Applied Research Facility
2026-08-20 11:00 · Yahoo
PyroGenesis Announces $1.4 Million Contract to Supply Two Plasma Torches to European Mining, Metallurgy & Materials Entity
2026-08-19 11:00 · Yahoo
PyroGenesis Provides Corporate Update on Fumed Silica Business Line
2026-08-17 11:00 · Yahoo
PyroGenesis Announces Second Quarter 2026 Results: Revenue of $4.4 Million, Up 47% Year-Over-Year for Best Q2 Since 2022
2026-08-07 01:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.